Biomarkers and Pharmacogenomics in Kidney Transplantation

L. E. Crowley; M. Mekki; S. Chand

doi:10.1007/s40291-018-0349-5

Biomarkers and Pharmacogenomics in Kidney Transplantation

L. E. Crowley
, M. Mekki
, S. Chand

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

This review is focused on present and future biomarkers, along with pharmacogenomics used in clinical practice for kidney transplantation. It aims to highlight biomarkers that could potentially be used to improve kidney transplant early and long-term graft survival, but also potentially patient co-morbidity. Future directions for improving outcomes are discussed, which include immune tolerance and personalising immunosuppression regimens.

Original language	English
Pages (from-to)	537-550
Number of pages	14
Journal	Molecular Diagnosis and Therapy
Volume	22
Issue number	5
DOIs	https://doi.org/10.1007/s40291-018-0349-5
State	Published - 1 Oct 2018
Externally published	Yes

Access to Document

10.1007/s40291-018-0349-5

Cite this

@article{b36b07f005d24876a114eb1dd7fbfc8c,

title = "Biomarkers and Pharmacogenomics in Kidney Transplantation",

abstract = "This review is focused on present and future biomarkers, along with pharmacogenomics used in clinical practice for kidney transplantation. It aims to highlight biomarkers that could potentially be used to improve kidney transplant early and long-term graft survival, but also potentially patient co-morbidity. Future directions for improving outcomes are discussed, which include immune tolerance and personalising immunosuppression regimens.",

author = "Crowley, \{L. E.\} and M. Mekki and S. Chand",

note = "Publisher Copyright: {\textcopyright} 2018, Springer International Publishing AG, part of Springer Nature.",

year = "2018",

month = oct,

day = "1",

doi = "10.1007/s40291-018-0349-5",

language = "English",

volume = "22",

pages = "537--550",

journal = "Molecular Diagnosis and Therapy",

issn = "1177-1062",

publisher = "Adis",

number = "5",

}

TY - JOUR

T1 - Biomarkers and Pharmacogenomics in Kidney Transplantation

AU - Crowley, L. E.

AU - Mekki, M.

AU - Chand, S.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - This review is focused on present and future biomarkers, along with pharmacogenomics used in clinical practice for kidney transplantation. It aims to highlight biomarkers that could potentially be used to improve kidney transplant early and long-term graft survival, but also potentially patient co-morbidity. Future directions for improving outcomes are discussed, which include immune tolerance and personalising immunosuppression regimens.

AB - This review is focused on present and future biomarkers, along with pharmacogenomics used in clinical practice for kidney transplantation. It aims to highlight biomarkers that could potentially be used to improve kidney transplant early and long-term graft survival, but also potentially patient co-morbidity. Future directions for improving outcomes are discussed, which include immune tolerance and personalising immunosuppression regimens.

UR - https://www.scopus.com/pages/publications/85049596444

U2 - 10.1007/s40291-018-0349-5

DO - 10.1007/s40291-018-0349-5

M3 - Review article

C2 - 29971647

AN - SCOPUS:85049596444

SN - 1177-1062

VL - 22

SP - 537

EP - 550

JO - Molecular Diagnosis and Therapy

JF - Molecular Diagnosis and Therapy

IS - 5

ER -

Biomarkers and Pharmacogenomics in Kidney Transplantation

Abstract

Access to Document

Fingerprint

Cite this